Rituximab failure in a patient with monoclonal gammopathy of undetermined significance (MGUS)-associated acquired von Willebrand syndrome.
Grimaldi
David
D
Service de Médecine Interne, Hôpital Henri Mondor, 52 Av. du Maréchal de Lattre de Tassigny, 94010 Créteil cedex, France.
Bartolucci
Pablo
P
Gouault-Heilmann
Michele
M
Martin-Toutain
Isabelle
I
Khellaf
Mehdi
M
Godeau
Bertrand
B
D000368:Aged; D000911:Antibodies, Monoclonal / Q000009:adverse effects*; D058846:Antibodies, Monoclonal, Murine-Derived; D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000627:therapeutic use; D008297:Male; D010265:Paraproteinemias / Q000097:blood / Q000150:complications* / Q000628:therapy*; D000069283:Rituximab; D017211:Treatment Failure; D014842:von Willebrand Diseases / Q000097:blood / Q000209:etiology* / Q000628:therapy*
D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D016756:Immunoglobulins, Intravenous; D000069283:Rituximab